A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/08/2007	US20070258986 Targeted Delivery System for Bioactive Agents
11/08/2007	US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007	US20070258977 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/08/2007	US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007	US20070258973 Diagnostics and Therapeutics for Diseases Associated with Tripeptidyl-Peptidase 2(Tpp2)
11/08/2007	US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand
11/08/2007	US20070258971 Methods for Treating Local Tracheal, Bronchial or Alveolar Bleeding or Hemoptysis
11/08/2007	US20070258970 Methods for Inhibiting Hiv and Other Viral Infections by Modulating Ceramide Metabolism
11/08/2007	US20070258969 Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
11/08/2007	US20070258968 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
11/08/2007	US20070258967 Purification method of reduced coenzyme q10
11/08/2007	US20070258966 Stabilization method of reduced coenzyme q10
11/08/2007	US20070258961 Cholesterol efflux and uses thereof
11/08/2007	US20070258959 CD4+CD25- T CELLS AND Tr1-LIKE REGULATORY T CELLS
11/08/2007	US20070258955 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/08/2007	US20070258951 Methods of treating cardiac disorders
11/08/2007	US20070258949 Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
11/08/2007	US20070258947 Depeptidized Inhibitors of Hepatitis C Virus NS3 Protease
11/08/2007	US20070258946 Combination Therapy for Treating Hepatitis C Virus Infection
11/08/2007	US20070258945 G-GSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
11/08/2007	US20070258944 Multiple cytokine protein complexes
11/08/2007	US20070258941 Methods and compositions for remediation of disc herniation by modifying structure
11/08/2007	US20070258914 casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria containing Lactobacillus helveticusto provide a fermented dairy product containing metalloproteinases inhibitory agent
11/08/2007	US20070258899 Diagnostic and therapeutic agents
11/08/2007	US20070258895 Estrogen Receptors and Methods of Use
11/08/2007	DE10312259B4 Kosmetische oder dermopharmazeutische Zusammensetzung, umfassend ein Enzym, das in einem wässrigen Medium unlöslich ist, sowie deren Verwendung Cosmetic or dermopharmaceutical composition comprising an enzyme, which is insoluble in an aqueous medium, and the use thereof
11/08/2007	DE10054303B4 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases
11/08/2007	CA2771087A1 Use of antisecretory factors for treating intraocular hypertension
11/08/2007	CA2650903A1 Antimicrobial linear peptides
11/08/2007	CA2650864A1 Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis
11/08/2007	CA2650597A1 Method and composition for treating and preventing tumor metastasis in vivo
11/08/2007	CA2650589A1 Antisecretory protein for the treatment of compartment syndrome
11/08/2007	CA2650485A1 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
11/08/2007	CA2650344A1 Use of antisecretory protein to treat intraocular hypertension
11/08/2007	CA2650341A1 Augmentation of titer for vaccination in animals
11/08/2007	CA2650132A1 Further medical uses of antisecretory protein
11/08/2007	CA2648077A1 Parenteral low dose type 1 interferons for bladder cancer
11/08/2007	CA2647815A1 Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia
11/08/2007	CA2647336A1 Cox-2 inhibitor
11/08/2007	CA2647277A1 Method for using boc/cdo to modulate hedgehog signaling
11/08/2007	CA2647260A1 Solid support reagents for synthesis
11/08/2007	CA2646048A1 Compositions and methods of use for antibodies of c-met
11/08/2007	CA2631961A1 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/07/2007	EP1852511A1 Bovine immunodeficiency virus (biv) based vectors
11/07/2007	EP1852506A2 Lipophilic derivatives of double-stranded ribonucleic acid
11/07/2007	EP1852505A1 Mutations in ion channels
11/07/2007	EP1852441A2 Agents that modulate EPH receptor activity
11/07/2007	EP1852440A1 Alpha-conotoxin peptides
11/07/2007	EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007	EP1852178A1 Process for producing coated fine particle
11/07/2007	EP1852128A1 An anti HSP90 antibody
11/07/2007	EP1852124A1 Fibrosis inhibitor for implanted organ
11/07/2007	EP1852123A2 Activation and inhibition of the immune system
11/07/2007	EP1852114A1 COMPOSITION CONTAINING DIHOMO-(gamma)-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT
11/07/2007	EP1851549A2 Pharmaceutical compositions for the treatment of prostate cancer
11/07/2007	EP1851536A2 Polypeptide formulations and methods for making, using and characterizing them
11/07/2007	EP1851342A2 Detection of biomarkers for neuropsychiatric disorders
11/07/2007	EP1851308A1 Cd4+ cd25+ t-cells activated to a specific antigen
11/07/2007	EP1851241A2 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor
11/07/2007	EP1851240A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
11/07/2007	EP1851237A2 Pharmaceutical compositions for treating or preventing bone conditions
11/07/2007	EP1850875A1 Sustained release composition of protein drug
11/07/2007	EP1850863A1 Use of botulinum toxin for prolonged local desensitization
11/07/2007	EP1850862A2 Methods of treating disease with glycosylated interferon
11/07/2007	EP1850861A1 Systemic treatment of infections with defensins
11/07/2007	EP1850860A2 Prostate stem cell antigen vaccines and uses thereof
11/07/2007	EP1850846A1 Composition comprising a jnk inhibitor and cyclosporin
11/07/2007	EP1722811B1 Use of hepatocyte growth factor for promoting induction of vascular differentiation
11/07/2007	EP1534311B1 Method for identifying modulators of ion channels
11/07/2007	EP1374901B9 Graft rejection suppressors
11/07/2007	EP1362127B1 Serpin drugs for treatment of hiv infection and method of use thereof
11/07/2007	EP1317276B1 Therapeutic use of a recombinant erythropoietin omega having high activity and reduced side effects
11/07/2007	EP1276473B1 Pharmaceutical formulations for dry powder inhalers
11/07/2007	EP1042288B1 Tripeptidyl peptidase inhibitors
11/07/2007	EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
11/07/2007	EP1017413B2 Liquid interferon-beta formulations
11/07/2007	EP1003379B1 Novel phytase
11/07/2007	EP0950663B1 Method for stabilizing useful proteins and useful protein compositions
11/07/2007	EP0814785B1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility
11/07/2007	CN101068917A Composition based on arthrospira and its application
11/07/2007	CN101068833A Method for producing carboxy-terminal amidified peptides
11/07/2007	CN101068832A Fusion protein comprising a bh3-domain of a bh3-only protein
11/07/2007	CN101068830A Protein allergens derivative
11/07/2007	CN101068828A Acylsulfonamide compounds as inhibitors of hepatitis c virus NS3 serine protease
11/07/2007	CN101068565A Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
11/07/2007	CN101068564A Antitumor combinations containing a vegf inhibitor and 5fu or one of its derivatives
11/07/2007	CN101068563A Novel antimicrobial peptides
11/07/2007	CN101068562A Method of treating, preventing, inhibiting or reducing damage to cardiac tissue
11/07/2007	CN101068561A Method and composition for enhancing anti-angiogenic therapy
11/07/2007	CN101068560A Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent
11/07/2007	CN101068556A Pilose antler nano-products containing enriched insulin-like growth factor and producing method thereof
11/07/2007	CN101068547A Dose forms comprising VX-950 and their dosage regimen
11/07/2007	CN101067135A Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/07/2007	CN101067128A Prepn process and medicine composition of natural arginine esterase
11/07/2007	CN101067000A New-type long-acting thymulin and its application
11/07/2007	CN101066993A Recombinant staphylococcus aureus enterotoxin M and its prepn and application
11/07/2007	CN101066992A Peptides and related compounds having thrombopoietic activity
11/07/2007	CN101066970A Method for preparing medicine composition containing 1,3 oxathiolane nucleoside analogue
11/07/2007	CN101066447A Group b streptococcus proteins, and their use
11/07/2007	CN101066446A Chinese medicine composition for treating enteritis

1 ... 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 ... 3163